BridgeBio Oncology Therapeutics Inc
BBOT
NASDAQ
Biotechnology
$9.06
USD
-0.17 (-1.84%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $743.39M
Volume 227.5K
Price Target
$22.00 – $22.00
USD
The 1 analysts offering 1-year price forecasts have a max estimate of $22.00 and a min estimate of $22.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$22.00
-$4.0 vs prior
Implied Upside
+142.8%
-44.1% vs prior
Analyst Covering
1
-1 vs prior period
Consensus
Buy
Unchanged vs prior
Signal Quality
Consensus Freshness
33%
Many ratings are older - consensus may be less current
Analyst Agreement
High
Targets are closely clustered - analysts agree more than usual
Mean vs Median
$0 Gap
Median and average are closely aligned - few outliers skewing the consensus
Analyst Consensus
Strong Sell
Hold
Strong Buy
Buy
1 Buy
0 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
1 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Mazahir Alimohamed | Oppenheimer | Buy | Resumed | 1 month ago | Plus | Plus | Plus |
Frequently Asked Questions
Similar Stocks
GYRE
Gyre Therapeutics Inc
$6.68
▲ +2.1%
ACHV
Achieve Life Sciences Inc
$7.59
▲ +4.7%
MNPR
Monopar Therapeutics Inc
$113.04
▲ +2.4%
NGNE
Neurogene Inc
$36.14
▲ +1.4%
CTMX
CytomX Therapeutics Inc
$3.36
▲ +0.3%
STTK
Shattuck Labs Inc
$7.42
▲ +1.4%
RGNX
Regenxbio Inc
$10.77
▲ +1.0%
IRWD
Ironwood Pharmaceuticals Inc
$4.31
▲ +5.6%
IMMX
Immix Biopharma Inc
$10.97
▲ +0.5%